DCF — ST. MARYS MEDICAL CENTER INC.
Enterprise Value: $-792.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-792.8M
Enterprise Value
$-251.7M
PV of Cash Flows
$-541.1M
PV of Terminal Value
$-871.4M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $523.1M | $-48.9M | -9.0% | $-71.0M | $-64.6M |
| Year 2 | $538.7M | $-45.0M | -8.0% | $-67.8M | $-56.0M |
| Year 3 | $554.9M | $-40.8M | -7.0% | $-64.3M | $-48.3M |
| Year 4 | $571.6M | $-39.1M | -7.0% | $-63.3M | $-43.3M |
| Year 5 | $588.7M | $-38.8M | -7.0% | $-63.8M | $-39.6M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-792.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$507.8M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09848318744172407
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5